
Lynne Dunsford is a Senior Study Manager with extensive experience across pre-clinical research, discovery immunology, and cell therapy. She began her career at the bench, developing a strong technical foundation in assay design, experimental development, and troubleshooting - expertise that continues to inform her scientific leadership and strategic decision making.
With hands-on experience operating withing multiple regulatory and research environments, Lynne brings a rigorous, detail-driven approach to study execution. She is adept at aligning scientific objectives with practical delivery, ensuring studies are designed and conducted with clarity, rigour, and reproducibility. Her technical background spans the design and optimisation of diverse immunological assays across therapeutic areas including inflammatory disease, immuno-oncology, and allergy, enabling her to provide both high-level scientific oversight and pragmatic experimental insight.
Over the course of her career, Lynne has progressed from laboratory scientist to a leader and mentor, recognised for her calm solution-focused approach in complex or fast paced settings. She is passionate about developing people and fostering collaborative, supportive team environments that enable scientific excellence. Whether guiding study design, leading cross-functional programmes, or implementing new assays platforms, Lynne combines technical depth with thoughtful leadership to deliver high-quality, impactful research.
Resources

Videos
2 April 2025
|2 min read
First presented at the NextGen Biomed 2025 conference, RoukenBio's Senior Study Manager and immunology expert Lynne Dunsford showcases our specialist immuno-oncology services.

Research Posters
18 August 2023
|3 min read
Explore our research poster modelling the tumour microenvironment featuring NK cells, macrophages and T cells.

Technical Presentations
20 October 2022
|5 min read
RoukenBio has established an in vitro T cell exhaustion model that can be used to assess candidate immunotherapeutics. Find out more about our unique approach.